REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $557,000 | +139.1% | 20,619 | +146.8% | 0.01% | +133.3% |
| Q3 2021 | $233,000 | -15.0% | 8,355 | -9.5% | 0.01% | -33.3% |
| Q2 2021 | $274,000 | -30.6% | 9,228 | -41.3% | 0.01% | -62.5% |
| Q3 2020 | $395,000 | -15.6% | 15,718 | -18.1% | 0.02% | -25.0% |
| Q2 2020 | $468,000 | +32.2% | 19,180 | -19.7% | 0.03% | +10.3% |
| Q1 2020 | $354,000 | -49.5% | 23,900 | -44.7% | 0.03% | -52.5% |
| Q4 2019 | $701,000 | +109.3% | 43,200 | +297.1% | 0.06% | +52.5% |
| Q1 2018 | $335,000 | – | 10,878 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |